Prescribing pre-exposure prophylaxis in general practice

Abstract

Background Pre-exposure prophylaxis (PrEP) is a highly effective method of human immunodeficiency virus (HIV) prevention available to prescribe on the Pharmaceutical Benefits Scheme general schedule. Objective The aim of this article is to provide information and guidance to general practitioners (GPs) and other healthcare providers on providing PrEP, and to discuss efficacy, adverse effects, monitoring and further resources. Discussion GPs can play a central role in discussing HIV prevention strategies for people who may be at risk of HIV. An open and engaging discussion will assist patients in making an informed decision on whether PrEP is suitable for them.